Guixiu Shi

3.4k total citations
122 papers, 2.4k citations indexed

About

Guixiu Shi is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Guixiu Shi has authored 122 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 33 papers in Molecular Biology and 32 papers in Rheumatology. Recurrent topics in Guixiu Shi's work include Salivary Gland Disorders and Functions (24 papers), Systemic Lupus Erythematosus Research (16 papers) and T-cell and B-cell Immunology (16 papers). Guixiu Shi is often cited by papers focused on Salivary Gland Disorders and Functions (24 papers), Systemic Lupus Erythematosus Research (16 papers) and T-cell and B-cell Immunology (16 papers). Guixiu Shi collaborates with scholars based in China, United States and Canada. Guixiu Shi's co-authors include Yuan Liu, Hongyan Qian, Yan He, Jiangping Wu, Shiju Chen, Lihua Duan, Frances E. Lund, Zhixin Zhang, Jianying Zhang and Xuan Zhang and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Guixiu Shi

117 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guixiu Shi China 28 857 759 448 314 275 122 2.4k
Anna M. Piccinini United Kingdom 20 1.2k 1.4× 950 1.3× 331 0.7× 407 1.3× 264 1.0× 33 2.9k
George D. Kalliolias United States 21 1.1k 1.3× 779 1.0× 484 1.1× 449 1.4× 210 0.8× 35 2.5k
Dong Hyun Sohn South Korea 18 722 0.8× 921 1.2× 468 1.0× 268 0.9× 182 0.7× 51 2.2k
Zohreh Babaloo Iran 27 880 1.0× 691 0.9× 317 0.7× 362 1.2× 162 0.6× 98 2.4k
Jan Ehrchen Germany 26 1.4k 1.6× 958 1.3× 330 0.7× 225 0.7× 385 1.4× 64 2.9k
Eleni Douni Greece 27 1.4k 1.6× 1.2k 1.6× 435 1.0× 635 2.0× 323 1.2× 58 3.2k
Matthias Pierer Germany 24 919 1.1× 600 0.8× 498 1.1× 258 0.8× 219 0.8× 51 2.0k
Stefan Uderhardt Germany 20 792 0.9× 928 1.2× 322 0.7× 207 0.7× 249 0.9× 34 2.1k
Hiroki Mitoma Japan 24 1.3k 1.6× 767 1.0× 714 1.6× 320 1.0× 375 1.4× 68 2.9k
K Nishioka Japan 30 888 1.0× 630 0.8× 847 1.9× 305 1.0× 218 0.8× 100 2.5k

Countries citing papers authored by Guixiu Shi

Since Specialization
Citations

This map shows the geographic impact of Guixiu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guixiu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guixiu Shi more than expected).

Fields of papers citing papers by Guixiu Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guixiu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guixiu Shi. The network helps show where Guixiu Shi may publish in the future.

Co-authorship network of co-authors of Guixiu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Guixiu Shi. A scholar is included among the top collaborators of Guixiu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guixiu Shi. Guixiu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jan, Nasrullah, et al.. (2025). Cell membrane-coated nanoparticles: A new frontier in atherosclerosis therapy. Chemical Engineering Journal. 524. 169183–169183. 2 indexed citations
2.
Jan, Nasrullah, Hassan Shah, & Guixiu Shi. (2025). Biomimetic approaches against accelerated blood clearance (ABC) phenomenon of nanoparticulate drug delivery systems. International Journal of Pharmaceutics. 680. 125753–125753. 3 indexed citations
3.
Yang, Qin, Yan Li, Hongyan Qian, et al.. (2025). Vientovirus capsid protein mimics autoantigens and contributes to autoimmunity in Sjögren’s disease. Nature Microbiology. 10(10). 2591–2602.
4.
Sun, Huimin, et al.. (2024). Non-negligible prevalence of focal lymphocytic sialadenitis in minor salivary glands of non-Sjögren's disease individuals. Clinical and Experimental Rheumatology. 42(12). 2499–2506.
5.
Chen, Shiju, Hongyan Qian, Fan Dai, et al.. (2024). Detection of anti-calreticulin antibody in the sera of Chinese patients with primary Sjögren syndrome. Seminars in Arthritis and Rheumatism. 68. 152488–152488.
8.
Wu, Yuanhui, et al.. (2022). The serum uric acid is longitudinally related to patients global assessment of disease activity in male patients with axial spondyloarthritis. BMC Musculoskeletal Disorders. 23(1). 717–717. 2 indexed citations
9.
Zhang, Qi, Ying Wang, Bin Wang, et al.. (2022). Expression of CFTR, a hallmark gene of ionocytes, is downregulated in salivary glands of Sjögren’s syndrome patients. Arthritis Research & Therapy. 24(1). 263–263. 3 indexed citations
10.
Chen, Rongjuan, Hongyan Qian, Xiaoqing Yuan, et al.. (2021). Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes. Journal of Immunology Research. 2021. 1–8. 5 indexed citations
11.
Qian, Hongyan, Rongjuan Chen, Bin Wang, et al.. (2020). Associations of Platelet Count with Inflammation and Response to Anti-TNF-α Therapy in Patients with Ankylosing Spondylitis. Frontiers in Pharmacology. 11. 559593–559593. 18 indexed citations
12.
Xu, Su, Yijian Chen, Ying Li, et al.. (2017). New Subclass B1 Metallo-β-Lactamase Gene from a Clinical Pathogenic Myroides odoratus Strain. Microbial Drug Resistance. 24(7). 909–914. 5 indexed citations
13.
Zhou, Weidong, Ying Wang, Rongfeng Wu, et al.. (2017). MicroRNA-488 and -920 regulate the production of proinflammatory cytokines in acute gouty arthritis. Arthritis Research & Therapy. 19(1). 203–203. 60 indexed citations
14.
Shen, Long, Kishore S. Malyavantham, Lakshmanan Suresh, et al.. (2016). Early Detection of Sjögren’s Syndrome; Sensitivity and Specificity of the Sjö® Diagnostic Test. Investigative Ophthalmology & Visual Science. 57(12). 5681–5681. 1 indexed citations
15.
Li, Yan, Dashan Wang, Yantang Wang, & Guixiu Shi. (2014). Progress of Biological Agents on Psoriatic Arthritis. Current Pharmaceutical Biotechnology. 15(6). 525–534. 3 indexed citations
16.
Liu, Yuan, et al.. (2012). Interstitial lung disease in clinically amyopathic dermatomyositis (CADM) patients: a retrospective study of 41 Chinese Han patients. Rheumatology International. 33(5). 1295–1302. 31 indexed citations
17.
Wang, Dashan, Yan Li, Yugao Zhang, Yuan Liu, & Guixiu Shi. (2012). High Throughput Screening (HTS) in Identification New Ligands and Drugable Targets of G Protein-Coupled Receptors (GPCRs). Combinatorial Chemistry & High Throughput Screening. 15(3). 232–241. 5 indexed citations
18.
Partida‐Sánchez, Santiago, Andreas Gasser, Ralf Fliegert, et al.. (2007). Chemotaxis of Mouse Bone Marrow Neutrophils and Dendritic Cells Is Controlled by ADP-Ribose, the Major Product Generated by the CD38 Enzyme Reaction. The Journal of Immunology. 179(11). 7827–7839. 116 indexed citations
19.
Shi, Guixiu, et al.. (2005). Tumor Vaccine Based on Cell Surface Expression of DcR3/TR6. The Journal of Immunology. 174(8). 4727–4735. 7 indexed citations
20.
Shi, Guixiu, Yulian Wu, Jun Zhang, & Jiangping Wu. (2003). Death Decoy Receptor TR6/DcR3 Inhibits T Cell Chemotaxis In Vitro and In Vivo. The Journal of Immunology. 171(7). 3407–3414. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026